Literature DB >> 15632056

The C-terminal domain of RNA polymerase II functions as a phosphorylation-dependent splicing activator in a heterologous protein.

Scott Millhouse1, James L Manley.   

Abstract

RNA polymerase II, and specifically the C-terminal domain (CTD) of its largest subunit, has been demonstrated to play important roles in capping, splicing, and 3' processing of mRNA precursors. But how the CTD functions in these reactions, especially splicing, is not well understood. To address some of the basic questions concerning CTD function in splicing, we constructed and purified two fusion proteins, a protein in which the CTD is positioned at the C terminus of the splicing factor ASF/SF2 (ASF-CTD) and an RS domain deletion mutant protein (ASFDeltaRS-CTD). Significantly, compared to ASF/SF2, ASF-CTD increased the reaction rate during the early stages of splicing, detected as a 20- to 60-min decrease in splicing lag time depending on the pre-mRNA substrate. The increased splicing rate correlated with enhanced production of prespliceosomal complex A and the early spliceosomal complex B but, interestingly, not the very early ATP-independent complex E. Additional assays indicate that the RS domain and CTD perform distinct functions, as exemplified by our identification of an activity that cooperates only with the CTD. Dephosphorylated ASFDeltaRS-CTD and a glutathione S-transferase-CTD fusion protein were both inactive, suggesting that an RNA-targeting domain and CTD phosphorylation were necessary. Our results provide new insights into the mechanism by which the CTD functions in splicing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632056      PMCID: PMC543425          DOI: 10.1128/MCB.25.2.533-544.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  68 in total

1.  Distinct roles for CTD Ser-2 and Ser-5 phosphorylation in the recruitment and allosteric activation of mammalian mRNA capping enzyme.

Authors:  C K Ho; S Shuman
Journal:  Mol Cell       Date:  1999-03       Impact factor: 17.970

2.  Phosphorylated RNA polymerase II stimulates pre-mRNA splicing.

Authors:  Y Hirose; R Tacke; J L Manley
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

Review 3.  Pre-mRNA splicing: awash in a sea of proteins.

Authors:  Melissa S Jurica; Melissa J Moore
Journal:  Mol Cell       Date:  2003-07       Impact factor: 17.970

4.  RNA polymerase II is an essential mRNA polyadenylation factor.

Authors:  Y Hirose; J L Manley
Journal:  Nature       Date:  1998-09-03       Impact factor: 49.962

5.  SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain.

Authors:  T Ø Tange; J Kjems
Journal:  J Mol Biol       Date:  2001-09-28       Impact factor: 5.469

6.  hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing.

Authors:  M Caputi; A Mayeda; A R Krainer; A M Zahler
Journal:  EMBO J       Date:  1999-07-15       Impact factor: 11.598

7.  Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing.

Authors:  R Tacke; M Tohyama; S Ogawa; J L Manley
Journal:  Cell       Date:  1998-04-03       Impact factor: 41.582

8.  RNA polymerase II accumulation in the promoter-proximal region of the dihydrofolate reductase and gamma-actin genes.

Authors:  Chonghui Cheng; Phillip A Sharp
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

9.  A nuclear matrix protein interacts with the phosphorylated C-terminal domain of RNA polymerase II.

Authors:  M Patturajan; X Wei; R Berezney; J L Corden
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

10.  CUS2, a yeast homolog of human Tat-SF1, rescues function of misfolded U2 through an unusual RNA recognition motif.

Authors:  D Yan; R Perriman; H Igel; K J Howe; M Neville; M Ares
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more
  22 in total

1.  The RNA polymerase C-terminal domain: a new role in spliceosome assembly.

Authors:  Charles J David; James L Manley
Journal:  Transcription       Date:  2011 Sep-Oct

2.  Human capping enzyme promotes formation of transcriptional R loops in vitro.

Authors:  Syuzo Kaneko; Chun Chu; Aaron J Shatkin; James L Manley
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-31       Impact factor: 11.205

3.  Functional coupling of last-intron splicing and 3'-end processing to transcription in vitro: the poly(A) signal couples to splicing before committing to cleavage.

Authors:  Frank Rigo; Harold G Martinson
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

Review 4.  RNA polymerase II C-terminal domain: Tethering transcription to transcript and template.

Authors:  Jeffry L Corden
Journal:  Chem Rev       Date:  2013-09-16       Impact factor: 60.622

5.  The RNA polymerase II C-terminal domain promotes splicing activation through recruitment of a U2AF65-Prp19 complex.

Authors:  Charles J David; Alex R Boyne; Scott R Millhouse; James L Manley
Journal:  Genes Dev       Date:  2011-05-01       Impact factor: 11.361

Review 6.  Coupling pre-mRNA processing to transcription on the RNA factory assembly line.

Authors:  Kuo-Ming Lee; Woan-Yuh Tarn
Journal:  RNA Biol       Date:  2013-02-07       Impact factor: 4.652

7.  Analogues and derivatives of oncrasin-1, a novel inhibitor of the C-terminal domain of RNA polymerase II and their antitumor activities.

Authors:  Shuhong Wu; Li Wang; Wei Guo; Xiaoying Liu; Jinsong Liu; Xiaoli Wei; Bingliang Fang
Journal:  J Med Chem       Date:  2011-04-06       Impact factor: 7.446

Review 8.  The RNA polymerase II CTD coordinates transcription and RNA processing.

Authors:  Jing-Ping Hsin; James L Manley
Journal:  Genes Dev       Date:  2012-10-01       Impact factor: 11.361

9.  TLS inhibits RNA polymerase III transcription.

Authors:  Adelene Y Tan; James L Manley
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

10.  Sleep loss disrupts Arc expression in dentate gyrus neurons.

Authors:  James E Delorme; Varna Kodoth; Sara J Aton
Journal:  Neurobiol Learn Mem       Date:  2018-04-07       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.